Alterations in glycosylation as biomarkers for cancer detection.
about
Mucin-Type O-Glycosylation in Gastric CarcinogenesisTurning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in CancerGlycomic Approaches for the Discovery of Targets in Gastrointestinal CancerMass Spectrometry-Based N-Glycomics of Colorectal CancerPosttranslational modifications in connexins and pannexinsRegulation of the metastatic cell phenotype by sialylated glycansProtein glycosylation in cancers and its potential therapeutic applications in neuroblastomaSerum glycoprotein-derived N- and O-linked glycans as cancer biomarkersEvolutional and clinical implications of the epigenetic regulation of protein glycosylation.Expression of ST3GAL4 leads to SLe(x) expression and induces c-Met activation and an invasive phenotype in gastric carcinoma cellsα3/4 Fucosyltransferase 3-dependent synthesis of Sialyl Lewis A on CD44 variant containing exon 6 mediates polymorphonuclear leukocyte detachment from intestinal epithelium during transepithelial migration.Sialic acid linkage differentiation of glycopeptides using capillary electrophoresis - electrospray ionization - mass spectrometrySalivary glycopatterns as potential biomarkers for diagnosis of gastric cancerGlycopeptide microarray for autoantibody detection in cancer.Analysis of glycoproteins for biomarker discoverySpecific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysisGlycophenotypic alterations induced by Pteridium aquilinum in mice gastric mucosa: synergistic effect with Helicobacter pylori infectionMeasurement of glycosylated alpha-fetoprotein improves diagnostic power over the native form in hepatocellular carcinomaGlycoproteomic analysis of glioblastoma stem cell differentiation.An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer.P53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infection.Glycomic analysis using glycoprotein immobilization for glycan extraction.Challenging the limits of detection of sialylated Thomsen-Friedenreich antigens by in-gel deglycosylation and nano-LC-MALDI-TOF-MS.O-glycan profiling of serum glycan for potential renal cancer biomarkers.Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies.Synthesis and cell-selective antitumor properties of amino acid conjugated tumor-associated carbohydrate antigen-coated gold nanoparticles.Anti-influenza neuraminidase inhibitor oseltamivir phosphate induces canine mammary cancer cell aggressiveness.NMR detection and characterization of sialylated glycoproteins and cell surface polysaccharidesCancer vaccines and carbohydrate epitopes.Evaluation of a combined glycomics and glycoproteomics approach for studying the major glycoproteins present in biofluids: Application to cerebrospinal fluid.Cancer cell surface induced peptide folding allows intracellular translocation of drug.Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery.A multiplexed bead assay for profiling glycosylation patterns on serum protein biomarkers of pancreatic cancer.N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.Anticancer β-hairpin peptides: membrane-induced folding triggers activity.Unmasking Heavily O-Glycosylated Serum Proteins Using Perchloric Acid: Identification of Serum Proteoglycan 4 and Protease C1 Inhibitor as Molecular Indicators for Screening of Breast Cancer.N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.Snail destabilizes cell surface Crumbs3a.Characteristic Changes in Cell Surface Glycosylation Accompany Intestinal Epithelial Cell (IEC) Differentiation: High Mannose Structures Dominate the Cell Surface Glycome of Undifferentiated Enterocytes.Definitive Screening Design Optimization of Mass Spectrometry Parameters for Sensitive Comparison of Filter and Solid Phase Extraction Purified, INLIGHT Plasma N-Glycans.
P2860
Q26740541-3D4359AC-E208-485B-A62F-1AB45EDEC7FBQ26744538-61256790-8FF8-4F2A-933F-3830C1A4E6F0Q26750872-9C2DCFE5-36F9-42E9-80C3-B1C9C0B10FE6Q26774414-59428027-6C40-4BBA-A868-B4934EDB5E32Q26825229-833E4F3C-D7E9-46CE-B770-A0BF217B9982Q27027559-E78D63F5-E993-40F0-86C0-269FCDDBB658Q28069952-6F0E0515-56F8-40B4-B6DE-80763EC14ED6Q28079101-A2924487-0A26-4E5B-9CAC-10D521915DA4Q30418119-85E35002-9A3B-49D3-AAFE-3C3D00681B9DQ31121236-4E3DF2D7-44CF-49A3-805F-F1B8B42DD6D3Q33720541-A0379F1D-7DC7-4256-9DB1-DDF99D1FE8E7Q33807752-9BBD7878-E8A6-4803-8FBD-EB3FA08F04E7Q33829287-722C9B5A-0CE3-4A98-AB4D-AE97245C9B9FQ33983835-DE1EC55C-CFE8-4DED-87EC-13528CAD5474Q34078215-794EDDB4-4B3D-4EFC-802A-917085536DE4Q34213758-1BC962CA-0C81-44C2-B076-7AC6E8719AAFQ34311876-072FDD3D-B737-45A6-938D-9D2136FEE83DQ34332296-34B1F429-2285-4DAB-B710-01AF837034CFQ34474236-5F08198D-684F-4CE1-A6A4-9C804A12DAEBQ34577155-24D989D8-001F-4E60-AA2C-FB258B81FC55Q34680930-C42E845C-F494-43D3-A39C-5FB6D3901CF0Q34729056-ECD48B28-57BA-4B35-8166-E3EB7FC8675EQ34775343-36953370-A046-4F9A-B70E-C911DD0D9EF5Q34777759-19B4F37F-A2CF-44A8-9843-03FA51E308E7Q35123891-0C8022EE-15E6-472B-8AC6-353B010D6079Q35162645-789006C4-0B7F-46BE-9BA0-FA3D51818596Q35303234-9CF91596-BB79-4DC0-8F6C-88D2A3164A4FQ35419226-C04212A5-1821-4095-A1C6-CC495407966CQ35525289-BF775AC1-C806-40D7-862B-30D12B362243Q35687506-9452530A-97A9-46FD-988D-DB1840355D76Q35691164-EDD864C4-DE52-4A0A-898B-44C62CD121ADQ35692128-13B1A47D-B576-4AC8-90E6-71AE81FE980BQ35794070-EACCED77-16BA-4DAE-8F8B-449B07CD0922Q35874750-F7D4CD28-503C-46B0-A82B-CBF613C8FD9EQ35884187-BED11D09-F70C-4FBA-9D43-9FC61AB6DF5EQ35927365-20CC767D-625A-422C-858E-7144C57D9FC0Q36076879-3A3AC2E5-174D-4E40-9C84-A08A86117B35Q36094987-FFD47263-83AE-4623-A65E-6EA81A4685D8Q36263012-EDFE5010-FF1B-44F7-9453-7F86BDE06878Q36331236-16970830-E598-4235-A86F-A58F57E1215D
P2860
Alterations in glycosylation as biomarkers for cancer detection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alterations in glycosylation as biomarkers for cancer detection.
@en
Alterations in glycosylation as biomarkers for cancer detection.
@nl
type
label
Alterations in glycosylation as biomarkers for cancer detection.
@en
Alterations in glycosylation as biomarkers for cancer detection.
@nl
prefLabel
Alterations in glycosylation as biomarkers for cancer detection.
@en
Alterations in glycosylation as biomarkers for cancer detection.
@nl
P2093
P356
P1476
Alterations in glycosylation as biomarkers for cancer detection.
@en
P2093
Catarina Gomes
Celso A Reis
Hugo Osorio
Leonor David
Luisa Silva
P304
P356
10.1136/JCP.2009.071035
P407
P577
2010-04-01T00:00:00Z